Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Communication

Enhancement of Endotoxic Shock by N-Acetylmuramyl-l-alanyl-(l-seryl)-d-isoglutamine (Muramyl Dipeptide)

Edgar E. Ribi, John L. Cantrell, Kenneth B. Von Eschen and Steven M. Schwartzman
Edgar E. Ribi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Cantrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth B. Von Eschen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Schwartzman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 1979
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We described elsewhere that the synergistic antitumor activity of endotoxic extracts from Re mutants of gram-negative bacteria and trehalose mycolate against guinea pig syngeneic line 10 tumor was abrogated after peptidic substances accompanying these extracts had been removed. This activity could be restored by combining peptide-free endotoxin either with cell wall skeleton from Bacillus Calmette-Guérin, a polymeric mycolic acid-arabinogalactan-mucopeptide complex, or with a combination of two separate components, trehalose dimycolate and N-acetylmuramyl-l-alanyl-(l-seryl)-d-isoglutamine (MDP). We report here that when a combination of endotoxin (150 µg) and a mixture of MDP (150 µg) and trehalose dimycolate (150 µg) was inoculated into established dermal tumors, a significant number of the animals died, presumably of endotoxic shock. All surviving animals suffered severe but temporary lethargy. When administered alone intradermally in the dose levels tested, none of the components caused severe lethargy or lethality. The lethal effects of 150 µg of MDP also occurred in combination with relatively weak endotoxic products, such as Pseudomonas vaccine (Pseudogen), and these effects did not depend upon the presence of malignant tissue. Guinea pigs inoculated i.v. were even more susceptible inasmuch as the addition of as little as 6 µg of MDP to 150 µg of Pseudogen, itself not lethal, caused the death of 80% of the animals.

Footnotes

  • ↵1 To whom requests for reprints should be addressed.

  • Received June 4, 1979.
  • Accepted September 4, 1979.
  • ©1979 American Association for Cancer Research.
PreviousNext
Back to top
November 1979
Volume 39, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Enhancement of Endotoxic Shock by N-Acetylmuramyl-l-alanyl-(l-seryl)-d-isoglutamine (Muramyl Dipeptide)
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Enhancement of Endotoxic Shock by N-Acetylmuramyl-l-alanyl-(l-seryl)-d-isoglutamine (Muramyl Dipeptide)
Edgar E. Ribi, John L. Cantrell, Kenneth B. Von Eschen and Steven M. Schwartzman
Cancer Res November 1 1979 (39) (11) 4756-4759;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Enhancement of Endotoxic Shock by N-Acetylmuramyl-l-alanyl-(l-seryl)-d-isoglutamine (Muramyl Dipeptide)
Edgar E. Ribi, John L. Cantrell, Kenneth B. Von Eschen and Steven M. Schwartzman
Cancer Res November 1 1979 (39) (11) 4756-4759;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Communication

  • Augmentation of the Response of Normal Mammary Epithelial Cells to Estradiol by Mammary Stroma
  • Aphidicolin-induced Endoreduplication in Chinese Hamster Cells
  • Immunohistochemical Detection of an Estrogen-regulated Protein by Monoclonal Antibodies
Show more Communication

Articles

  • Augmentation of the Response of Normal Mammary Epithelial Cells to Estradiol by Mammary Stroma
  • Aphidicolin-induced Endoreduplication in Chinese Hamster Cells
  • Immunohistochemical Detection of an Estrogen-regulated Protein by Monoclonal Antibodies
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement